Copyright Reports & Markets. All rights reserved.

Neuroprotection Market Research Report 2012-2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Objectives of Research
      • 1.1.1 Definition
      • 1.1.2 Specifications
    • 1.2 Market Segment
      • 1.2.1 by Type
        • 1.2.1.1 Free Radical Trapping Agents (Antioxidants)
        • 1.2.1.2 Glutamate Antagonists (Anti-Excitotoxic Agents)
        • 1.2.1.3 Apoptosis Inhibitors
        • 1.2.1.4 Anti-inflammatory Agents
        • 1.2.1.5 Neurotrophic Factors (NTFs)
        • 1.2.1.6 Metal Ion Chelators
        • 1.2.1.7 Stimulants
        • 1.2.1.8 Others
      • 1.2.2 by Application
        • 1.2.2.1 Prevention
        • 1.2.2.2 Treatment
      • 1.2.3 by Regions

    2 Industry Chain

    • 2.1 Industry Chain Structure
    • 2.2 Upstream
    • 2.3 Market
      • 2.3.1 SWOT
      • 2.3.2 Dynamics

    3 Environmental Analysis

    • 3.1 Policy
    • 3.2 Economic
    • 3.3 Technology
    • 3.4 Market Entry

    4 Market Segmentation by Type

    • 4.1 Market Size
      • 4.1.1 Free Radical Trapping Agents (Antioxidants) Market, 2013-2018
      • 4.1.2 Glutamate Antagonists (Anti-Excitotoxic Agents) Market, 2013-2018
      • 4.1.3 Apoptosis Inhibitors Market, 2013-2018
      • 4.1.4 Anti-inflammatory Agents Market, 2013-2018
      • 4.1.5 Neurotrophic Factors (NTFs) Market, 2013-2018
      • 4.1.6 Metal Ion Chelators Market, 2013-2018
      • 4.1.7 Stimulants Market, 2013-2018
      • 4.1.8 Others Market, 2013-2018
    • 4.2 Market Forecast
      • 4.2.1 Free Radical Trapping Agents (Antioxidants) Market Forecast, 2019-2024
      • 4.2.2 Glutamate Antagonists (Anti-Excitotoxic Agents) Market Forecast, 2019-2024
      • 4.2.3 Apoptosis Inhibitors Market Forecast, 2019-2024
      • 4.2.4 Anti-inflammatory Agents Market Forecast, 2019-2024
      • 4.2.5 Neurotrophic Factors (NTFs) Market Forecast, 2019-2024
      • 4.2.6 Metal Ion Chelators Market Forecast, 2019-2024
      • 4.2.7 Stimulants Market Forecast, 2019-2024
      • 4.2.8 Others Market Forecast, 2019-2024

    5 Market Segmentation by Application

    • 5.1 Market Size
      • 5.1.1 Prevention Market, 2013-2018
      • 5.1.2 Treatment Market, 2013-2018
    • 5.2 Market Forecast
      • 5.2.1 Prevention Market Forecast, 2019-2024
      • 5.2.2 Treatment Market Forecast, 2019-2024

    6 Market Segmentation by Region

    • 6.1 Market Size
      • 6.1.1 Asia-Pacific
        • 6.1.1.1 Asia-Pacific Market, 2012-2018
        • 6.1.1.2 Asia-Pacific Market by Type
        • 6.1.1.3 Asia-Pacific Market by Application
      • 6.1.2 North America
        • 6.1.2.1 North America Market, 2012-2018
        • 6.1.2.2 North America Market by Type
        • 6.1.2.3 North America Market by Application
      • 6.1.3 Europe
        • 6.1.3.1 Europe Market, 2012-2018
        • 6.1.3.2 Europe Market by Type
        • 6.1.3.3 Europe Market by Application
      • 6.1.4 South America
        • 6.1.4.1 South America Market, 2012-2018
        • 6.1.4.2 South America Market by Type
        • 6.1.4.3 South America Market by Application
      • 6.1.5 Middle East & Africa
        • 6.1.5.1 Middle East & Africa Market, 2012-2018
        • 6.1.5.2 Middle East & Africa Market by Type
        • 6.1.5.3 Middle East & Africa Market by Application
    • 6.2 Market Forecast
      • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
      • 6.2.2 North America Market Forecast, 2019-2024
      • 6.2.3 Europe Market Forecast, 2019-2024
      • 6.2.4 South America Market Forecast, 2019-2024
      • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

    7 Market Competitive

    • 7.1 Market by Vendors
    • 7.2 Market Concentration
    • 7.3 Price & Factors
    • 7.4 Marketing Channel

    8 Major Vendors

    • 8.1 Daiichi Sankyo Company
    • 8.2 Eli Lilly and Company
    • 8.3 Allergan
    • 8.4 Dr. Reddy’s Laboratories
    • 8.5 Teva Pharmaceutical
    • 8.6 Novartis
    • 8.7 AstraZeneca
    • 8.8 Astrocyte Pharmaceuticals
    • 8.9 F. Hoffmann-La Roche
    • 8.10 Biogen

    9 Conclusion

    Summary
    The Neuroprotection market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
    Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
    Free Radical Trapping Agents (Antioxidants)
    Glutamate Antagonists (Anti-Excitotoxic Agents)
    Apoptosis Inhibitors
    Anti-inflammatory Agents
    Neurotrophic Factors (NTFs)
    Metal Ion Chelators
    Stimulants
    Others
    Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
    Daiichi Sankyo Company
    Eli Lilly and Company
    Allergan
    Dr. Reddy’s Laboratories
    Teva Pharmaceutical
    Novartis
    AstraZeneca
    Astrocyte Pharmaceuticals
    F. Hoffmann-La Roche
    Biogen
    Based on Application, the report describes major application share of regional market. Application mentioned as follows:
    Prevention
    Treatment
    Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa

    Buy now